30.33 0.49 (1.64%) | 04-26 16:00 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 35.84 | 1-year : | 37.18 |
Resists | First : | 30.69 | Second : | 31.84 |
Pivot price | 30.43 | |||
Supports | First : | 28.82 | Second : | 23.98 |
MAs | MA(5) : | 30.33 | MA(20) : | 30.6 |
MA(100) : | 29.87 | MA(250) : | 0 | |
MACD | MACD : | -0.4 | Signal : | -0.3 |
%K %D | K(14,3) : | 44.3 | D(3) : | 48 |
RSI | RSI(14): 48 | |||
52-week | High : | 32.06 | Low : | 22.2 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ BKIV ] has closed above bottom band by 47.0%. Bollinger Bands are 63.2% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 6 days. This is a sign that the current trend might continue.
If tomorrow: | Open lower | Open higher |
High: | 30.36 - 30.51 | 30.51 - 30.63 |
Low: | 29.97 - 30.14 | 30.14 - 30.29 |
Close: | 30.07 - 30.34 | 30.34 - 30.57 |
To pursue its goal, the fund normally invests principally in equity securities of U.S. innovation-driven companies. The fund's sub-adviser considers innovation-driven companies to be (i) leading edge companies that, through their intellectual property, provide ground-breaking and/or innovative products and services that can be disruptive and transformative to existing business models and practices and (ii) business enterprises that are positively impacted by the transformation of their business models and practices through the use of such products or services. The fund is non-diversified.
Wed, 30 Aug 2023
The Benefits of Combining Active ETFs With AI - ETF Trends
Wed, 16 Aug 2023
Rosenbluth Digs Into the Types of AI Funds of TD Ameritrade - ETF Trends
Wed, 17 May 2023
BNY Mellon Launches Women’s Opportunities and Innovators ETFs - ETF Trends
Mon, 15 Aug 2016
Ascendis Pharma A/S (ASND) Stock Price, News & Analysis - MarketBeat
Mon, 15 Aug 2016
Align Technology (ALGN) Stock Price, News & Analysis - MarketBeat
Fri, 21 Aug 2015
Freshpet (FRPT) Stock Price, News & Analysis - NASDAQ - MarketBeat
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
Exchange:
NASDAQ
|
|
Sector:
Financial Services
|
|
Industry:
Asset Management
|
|
Shares Out | 0 (M) |
Shares Float | 0 (M) |
Held by Insiders | 0 (%) |
Held by Institutions | 0 (%) |
Shares Short | 0 (K) |
Shares Short P.Month | 0 (K) |
EPS | 0 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 0 |
Profit Margin | 0 % |
Operating Margin | 0 % |
Return on Assets (ttm) | 0 % |
Return on Equity (ttm) | 0 % |
Qtrly Rev. Growth | 0 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 0 |
EBITDA (p.s.) | 0 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | 0 (M) |
Levered Free Cash Flow | 0 (M) |
PE Ratio | 0 |
PEG Ratio | 0 |
Price to Book value | 0 |
Price to Sales | 0 |
Price to Cash Flow | 0 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |